Emergent BioSolutions Inc. — Director's Dealing 2020

Apr 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-04-17

Reporting Person: Havey Adam (EVP, Business Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-17	Common Stock	M	20414	$26.45	Acquired	54670	Direct
2020-04-17	Common Stock	S	20414	$65	Disposed	34256	Direct
2020-04-20	Common Stock	M	17009	$30.86	Acquired	51265	Direct
2020-04-20	Common Stock	S	17009	$69	Disposed	34256	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-17	Stock Options (Right to Buy)	$26.45	S	20414	Disposed	2022-03-09	Common Stock (20414.0)	Direct
2020-04-20	Stock Options (Right to Buy)	$30.86	S	17009	Disposed	2023-02-28	Common Stock (17009.0)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.

F2: Consists of options granted under the company's stock incentive plan as amended and restated.

F3: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.